Contact Information: Editorial Contact: Neal Leavitt Leavitt Communications 760-639-2900 or 760-212-9112 CDC Innovation Valery Huot Managing Partner Auriga Partners Philippe Granger Partner Rodolphe Lilamand Principal XAnge Private Equity Nicolas Rose Partner Rodolphe Menegaux Investment manager -- Legal advisor - Investors: Chammas & Marcheteau, Géraldine Vignat et Arys Serdjanian -- IP advisor - investors : Santarelli, Herbert Lewitter et Hélène Stankoff -- Legal advisor - Stantum : DDA Conseils, Laurent Delage et Joachim Bruneteau -- IP advisor - Stantum : BREDEMA - Pierre Breese -- Fund raising advisor, Stantum : Vadis Ventures - Baruk Pilo -- Financial Due Dilligence : Adwelsen, Florent Belliard -- Technical Due Dilligence : ALX Management, Alex Bezinge
Stantum Secures $13 Million in Series B Funding Round Co-Led by CDC Innovation and Auriga
| Source: Stantum Technologies
BORDEAUX, FRANCE--(Marketwire - March 10, 2009) - Stantum Technologies (www.stantum.com), a
pioneer developer of multi-touch sensing technologies, announced today it
has secured $13 million in Series B funding. CDC Innovation and Auriga
Partners co-led the round with XAnge Private Equity as historical investor
(2007).
Valery Huot, Managing partner of CDC Innovation, and Philippe Granger,
partner at Auriga Partners, have joined Stantum's board of directors,
alongside Nicolas Rose, partner at XAnge Private Equity.
According to Stantum CEO Etienne Paillard, the new funding will be used to
develop a worldwide sales and marketing organization in the U.S., Europe
and Asia; increase R&D capacity for next-generation sensing technologies
and new products; and establish and increase mass manufacturing
capabilities through partners.
Stantum, originally called JazzMutant, was founded in 2002 with an aim to
develop new human-machine interface standards for the creative industry.
In 2003, JazzMutant produced the world's first multi-touch screen that
could track an unlimited number of fingers at once. In 2005, JazzMutant
launched the first multi-touch product, the first such on the market.
Facing an ever-growing demand from various OEMs, the company began working
in 2006 to make its patented multi-touch technology available to
third-party integrators. In 2007, after a round of financing led by XAnge
Private Equity, JazzMutant became Stantum and officially launched its OEM
activity.
"Stantum has assembled an unparalleled engineering and top management team
with a proven track record of bringing leading products to market," said
Huot. "The company has already demonstrated cutting edge multi-touch
solutions that are attracting strong partner and customer interest for
mobile phones, navigation devices, and other consumer electronics
equipment."
"We are very excited to be supporting Stantum and are impressed by the
progress the company has made to date. Stantum's focused strategy and
unique multi-touch technologies provide a very strong foundation for future
success," added Granger.
Vadis Ventures, a corporate finance boutique focused on the high-tech
sector, advised Stantum through this round of financing.
About Stantum Technologies
Stantum Technologies (www.stantum.com) has been the pioneering company in
multi-touch display technology since 2002, and in 2005 was the first
company to market commercial products using a truly reliable multi-touch
user interface. Today, Stantum's breakthrough technology portfolio is
available under license for products covering every aspect of multi-touch
interactions: touch panels, controllers, intellectual property cores, and
software framework. Stantum is headquartered in Bordeaux, France.
About CDC Innovation
Founded in 1996, CDC Innovation (www.cdcinnovation.com) is an international
venture capital firm with its world headquarters in Paris and offices in
the Silicon Valley and Switzerland. With more than $575 million currently
under management, its focus is on venture investments, at both the early
and late stage, in two sectors: information technologies and life sciences.
Its aim is to create value by providing talented entrepreneurs with the
resources, experience and network necessary to turn world-class
technologies into great businesses.
About Auriga Partners
Auriga Partners (www.aurigapartners.com) is an independent venture capital
firm. Based in Paris, it invests in information technologies and life
sciences, in innovative high-potential ventures, in seed or early
development stages, in Europe, North America and Israel. Auriga Partners
manages three funds for a total of more than $420 million. Along with
investing the necessary capital, Auriga Partners also brings its
savoir-faire in developing and solidifying executive teams, organizing
companies, broadening their networks, and forming strategic and corporate
partnerships.
About XAnge Private Equity
Backed by leading European companies and financial institutions, XAnge
(www.xange.fr) is a unique private equity firm with EUR 350 million in
assets under management. XAnge was first launched in 2003 through the
creation of XAnge Capital, a unique European venture capital firm that
focuses on connectivity businesses and is sponsored by Groupe La Poste.
XAnge Private Equity -- an investment firm created by La Banque Postale --
ABN AMRO and management, has since developed a broader range of
competencies from venture capital to growth/transfer capital. As an active
minority shareholder, XAnge supports growth companies. XAnge has
deliberately positioned itself as a link between large corporations and
small and medium-sized businesses, to which it offers its expertise and an
industrial -- as opposed to a merely financial -- vision.
Last year, XAnge Private Equity established a branch in Munich which
received an advisory mandate to manage most of the IT technology portfolio
of Deutsche Venture Capital (DVC), Deutsche Bank's venture capital
subsidiary. This new entity enables XAnge to continue its international
expansion, and to pinpoint investment opportunities in Germany in the high
tech, telecom and clean tech sectors.